who should not take glp-1 drugs Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Meds: What They Really

10.1186/s12967-016-0985-7

However, because even in this pooled analyses the number of events of pancreatitis was still relatively small, we believe that these numbers alone neither prove nor disprove an association between incretin-based therapies and pancreatitis

doi: 10.1210/en.2012-1937 [DOI] [PubMed] [Google Scholar] 194

[DOI] [PubMed] [Google Scholar] 171

14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment